From: Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk
Haplotypea | Haplotype frequencies (%) | OR (95% CI) | ||||
---|---|---|---|---|---|---|
 | Cases (n = 1,408) | Controls (n = 2,612) | Crude modelb | Adjusted modelc | ||
FTCG | 0.178 | 0.183 | 1 | Â | 1 | Â |
FTCA | 0.036 | 0.049 | 0.76 | (0.51–1.15) | 0.81 | (0.53–1.23) |
FTTG | 0.124 | 0.116 | 1.12 | (0.87–1.43) | 1.09 | (0.84–1.40) |
FTTA | 0.025 | 0.025 | 1.10 | (0.69–1.77) | 1.16 | (0.71–1.88) |
FtCG | 0.117 | 0.113 | 1.07 | (0.83–1.38) | 1.06 | (0.82–1.39) |
FtCA | 0.052 | 0.035 | 1.50 | (1.07–2.12) | 1.43 | (1.00–2.05) |
FtTG | 0.076 | 0.079 | 0.98 | (0.76–1.27) | 1.04 | (0.80–1.36) |
FtTA | 0.016 | 0.015 | 1.05 | (0.59–1.87) | 0.98 | (0.54–1.79) |
fTCG | 0.109 | 0.117 | 0.97 | (0.75–1.24) | 0.97 | (0.75–1.26) |
fTCA | 0.028 | 0.023 | 1.19 | (0.72–1.96) | 1.17 | (0.70–1.95) |
fTTG | 0.080 | 0.083 | 0.98 | (0.75–1.26) | 1.04 | (0.80–1.35) |
fTTA | 0.011 | 0.011 | 1.07 | (0.48–2.37) | 0.93 | (0.41–2.09) |
ftCG | 0.048 | 0.041 | 1.19 | (0.84–1.69) | 1.19 | (0.82–1.72) |
ftCA | 0.024 | 0.027 | 0.94 | (0.57–1.55) | 0.95 | (0.56–1.64) |
ftTG | 0.065 | 0.072 | 0.94 | (0.71–1.25) | 0.94 | (0.70–1.27) |